H.E.L.P. Card Party CMT2A Fundraiser

by | Feb 10, 2016 | 0 comments

IMG_20160129_160141_129On Friday January 29, 2016 H.E.L.P. Fund supporters came together for the 7th annual H.E.L.P. Card Party at Broken Sound Country Club, Boca Raton.

Event hosts Iris and Nat Adler started the H.E.L.P. Fund (Help Elliot Live Proud) back in 2007 to benefit CMT2A, in honor of their grandson Elliot who lives with CMT2A.

The event kicked off with a scrumptious buffet brunch, followed by an upscale boutique where guests could shop for upscale and trendy jewelry, designer bags and clothing, fair-traded jewelry, and other unique items.

Guests were also able to participate in numerous raffles, and bids were placed on over 50 silent auction items.

HNF is proud to report that over $36,000 was raised for research for CMT2A at this annual event! Thank you to all the guests who attended, donations from friends that were unable to come, and the businesses that so generously donated.

Learn more on this topic

Related Blog Posts

Double Your Donation

Corporate matching gift programs are charitable giving programs setup by corporations in which the company matches donations made by employees to eligible nonprofit organizations. For example, if a donor works for Bank of America and donates $100 to the Hereditary Neuropathy Foundation, Bank of America will double the donation by also writing a check for $100.

Taking Matters Into Your Own Hands

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

Now GRIN is Accessible in 141 Different Languages!

Now GRIN is Accessible in 141 Different Languages!

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate. Why did we choose Google? Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Accelerating Patient Access to Investigational Drugs in 2015

Accelerating Patient Access to Investigational Drugs in 2015

Currently the FDA is working to update the process for physicians applying for accelerated patient access to investigational drugs, while the drug or biological product is being tested in clinical trials. This will also be important for the CMT community as clinical trials for this disease are being launched.

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Join the conversation

Leave a Comment


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news